Search Results - Shi‐Shan Yu
- Showing 1 - 4 results of 4
-
1
-
2
-
3
Rhodojaponin VI indirectly targets Cav2.2 channels via N-ethylmaleimide-sensitive fusion protein to alleviate neuropathic pain by Keliang Chen, Tao Wang, Yong Li, Jun Wu, Chengxiao Zhao, Sheng Liu, Fengrun Sun, Yehong Fang, Jiahuan Hu, Jinping Hu, Chong‐Jing Zhang, Haibo Yu, Chao Ma, Shi‐Shan Yu
Published 2023Artigo -
4
Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients by Jinlan Zhang, Yuhuan Li, Lulu Wang, Hongqi Liu, Shuaiyao Lu, Yong Liu, Ke Li, Bin Liu, Suyun Li, Fengmin Shao, Kun Wang, Ning Sheng, Rui Li, Jin‐Jin Cui, Peichun Sun, Chunxia Ma, Bo Zhu, Zhe Wang, Yuan-Hao Wan, Shi‐Shan Yu, Yongsheng Che, Chaoyang Wang, Chen Wang, Qiangqian Zhang, Limin Zhao, Xiaozhong Peng, Zhenshun Cheng, Junbiao Chang, Jian‐Dong Jiang
Published 2021Artigo
Search Tools:
Related Subjects
Biology
Medicine
Pharmacology
Bioinformatics
Chemistry
Disease
Drug
Immunology
Infectious disease (medical specialty)
Proteome
2019-20 coronavirus outbreak
ANTIRETROVIRAL AGENTS
Alkaloid
Analgesic
Anatomy
Antiretroviral therapy
Betacoronavirus
Biochemistry
Cancer research
Chronic pain
Computational biology
Computer science
Coronavirus Infections
Coronavirus disease 2019 (COVID-19)
Dorsal root ganglion
Dorsum
Drug discovery
Ecology
Glioma
Homing (biology)